Related Experiment Video
Updated: Sep 16, 2025

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
Prognostic significance of Lin28A protein expression in papillary thyroid carcinoma
Emel Tekin1, Damla Oflas2, Bartu Badak3
1Department of Pathology, Eskisehir Osmangazi University Faculty of Medicine, Eskisehir, Turkey.
Objective:
Papillary thyroid carcinoma (PTC) is the most commonly diagnosed endocrine malignancy. While the prognosis is favorable for most patients, the presence of lymph node metastasis is considered a high-risk factor for distant metastasis, the most important predictive factor for mortality. In this study, we aimed to investigate the association between Lin28A immunohistochemical expression and lymph node metastasis in PTC cases, accompanied by clinicopathological data.
Materials And Methods:
A total of 143 cases diagnosed with PTC who underwent bilateral total thyroidectomy and regional lymph node dissection were included in the study. The slides were re-evaluated according to the latest classification. The demonstrative tumor sections were stained with the Lin28A . Any degree of widespread cytoplasmic staining was considered positive.
Results:
72% of the cases were female, with an average age of 45.06 years. The most common tumor subtype were classic (70.6%), followed by the tall cell (11.9%). Lymph node metastasis was present in 51.7% of cases, while extrathyroidal spread was seen in 9.1%. The Lin28A staining was positive in 17.5% of cases. Statistically significant differences were found between Lin28A positivity and lymph node metastasis, perineural invasion, and extrathyroidal spread (respectively; P = 0.014, P = 0.004, P = 0.037).
Conclusions:
Lin28A , a proto-oncogene regulated by microRNA, has been shown to be overexpressed in many cancers with poor prognosis. This study's findings demonstrated Lin28A 's positive relationship with lymph node metastasis in PTC cases. The Lin28 molecular pathway may be a potential therapeutic target in cases where standard treatment is inadequate, especially in relapsed and resistant cases.
More Related Videos
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024